Document Detail

Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
MedLine Citation:
PMID:  21669247     Owner:  NLM     Status:  Publisher    
Whooping cough, caused by Bordetella pertussis, is reemerging in the vaccinated population. Antibody levels to pertussis antigens wane rapidly after both whole-cell (wP) and acellular pertussis (aP) vaccination and protection may largely depend on long-term B- and T-cell immunity. We studied the effect of wP and aP infant priming at 2, 3, 4 and 11 months according to the Dutch immunization program on pertussis-specific memory B-cell responses before and after a booster vaccination with either a high- or low-pertussis dose vaccine at 4 years of age. Purified B-cells were characterized by FACS-analysis and after polyclonal stimulation, memory B-cells were detected by ELISPOT-assays specific for pertussis toxin, filamentous haemagglutinin and pertactin. Before and after the booster, higher memory B-cell responses were measured in aP primed children compared with wP primed children. In contrast with antibody levels, no dose-effect was observed on the numbers of memory B-cell responses. In aP primed children a fifth high-dose aP vaccination tended to induce even lower memory B-cell responses than a low-dose aP booster. In both wP and aP primed children, the number of memory B-cells increased after the booster and correlated with the pertussis-specific antibody concentrations and observed affinity maturation. This study indicates that aP vaccinations in the first year of life induce higher pertussis-specific memory B-cell responses in children 4 years of age compared with Dutch wP primary vaccinations. Since infant aP vaccinations have improved protection against whooping cough in children despite waning antibody levels, this suggests that an enhanced memory B-cell pool induction may have an important role in protection. However, the pertussis-dose of the preschool booster needs to be considered depending on the vaccine used for priming to optimize long-term protection against whooping cough.
Lotte H Hendrikx; Lia G H de Rond; Kemal Oztürk; Reinier H Veenhoven; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Related Documents :
13413647 - Laboratory and vaccination studies with dried smallpox vaccines.
19200827 - Gender effects on humoral immune responses to smallpox vaccine.
2850277 - The transmission potential of monkeypox virus in human populations.
4988047 - Inactivated smallpox vaccine. a comparison of inactivation methods.
22624487 - Annual report: surveillance of adverse events following immunisation in australia, 2010.
10782077 - Vaccination against cysticercosis and hydatid disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-10
Journal Detail:
Title:  Vaccine     Volume:  -     ISSN:  1873-2518     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8406899     Medline TA:  Vaccine     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Ltd.
Centre for Infectious Disease and Control (Cib), National Institute for Public Health and the Environment, Bilthoven, The Netherlands; Research Centre Linnaeus Institute, Spaarne Hospital Hoofddorp, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Surfactant protein C is an essential constituent for mucosal adjuvanticity of Surfacten, acting as a...
Next Document:  Two genetic codes, one genome: Frameshifted primate mitochondrial genes code for additional proteins...